925
Views
98
CrossRef citations to date
0
Altmetric
Original Articles

Temporal parameters of spontaneous speech in Alzheimer's disease

, , , , &
Pages 29-34 | Published online: 04 Nov 2009
 

Abstract

This paper reports on four temporal parameters of spontaneous speech in three stages of Alzheimer's disease (mild, moderate, and severe) compared to age-matched normal controls. The analysis of the time course of speech has been shown to be a particularly sensitive neuropsychological method to investigate cognitive processes such as speech planning and production. The following parameters of speech were measured in Hungarian native-speakers with Alzheimer's disease and normal controls: articulation rate, speech tempo, hesitation ratio, and rate of grammatical errors. Results revealed significant differences in most of these speech parameters among the three Alzheimer's disease groups. Additionally, the clearest difference between the normal control group and the mild Alzheimer's disease group involved the hesitation ratio, which was significantly higher in the latter group. This parameter of speech may have diagnostic value for mild-stage Alzheimer's disease and therefore could be a useful aid in medical practice.

Acknowledgments

This work was supported by the Hungarian National Research Fund (OTKA F 61943, OTKA F 68666). We thank Ágnes Lukács, Melinda Boa, Karolina Janacsek for helpful comments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.